Skip to Main Content

Author Details

Christine A Olson
University of California los angeles
1988
51
32
Nevan J Krogan (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
38070135Ketogenic diet therapy for pediatric epilepsy is associated with alterations in the human gut microbiome that confer seizure resistance in mice.Cell Rep2023
35114110Rapid identification of neutralizing antibodies against SARS-CoV-2 variants by mRNA display.Cell Rep2022
36047699STENSL: Microbial Source Tracking with ENvironment SeLection.mSystems2022
34358434Alterations in the gut microbiota contribute to cognitive impairment induced by the ketogenic diet and hypoxia.Cell Host Microbe2021
33790226Gut microbial taxa elevated by dietary sugar disrupt memory function.Transl Psychiatry2021
31445165Emerging roles for the intestinal microbiome in epilepsy.Neurobiol Dis2020
32415096mRNA display with library of even-distribution reveals cellular interactors of influenza virus NS1.Nat Commun2020
32275853Toward Understanding Microbiome-Neuronal Signaling.Mol Cell2020
32492391Ketone Bodies Exert Ester-Ordinary Suppression of Bifidobacteria and Th17 Cells.Cell Metab2020
30007420The Gut Microbiota Mediates the Anti-Seizure Effects of the Ketogenic Diet.Cell2018
29804833The Gut Microbiota Mediates the Anti-Seizure Effects of the Ketogenic Diet.Cell2018
28441397Correction: Functional Constraint Profiling of a Viral Protein Reveals Discordance of Evolutionary Conservation and Functionality.PLoS Genet2017
28159892Systematic identification of anti-interferon function on hepatitis C virus genome reveals p7 as an immune evasion protein.Proc Natl Acad Sci U S A2017
28092661Interactions between the microbiota, immune and nervous systems in health and disease.Nat Neurosci2017
27573121The Microbial Olympics 2016.Nat Microbiol2016
26540565High-throughput identification of protein mutant stability computed from a double mutant fitness landscape.Protein Sci2016
27391790Adaptation in protein fitness landscapes is facilitated by indirect paths.Elife2016
26132554Functional Constraint Profiling of a Viral Protein Reveals Discordance of Evolutionary Conservation and Functionality.PLoS Genet2015
24169581Modelling clinical data shows active tissue concentration of daclatasvir is 10-fold lower than its plasma concentration.J Antimicrob Chemother2014
25455030A comprehensive biophysical description of pairwise epistasis throughout an entire protein domain.Curr Biol2014
25522661High-throughput profiling of point mutations across the HIV-1 genome.Retrovirology2014
25271282A comprehensive functional map of the hepatitis C virus genome provides a resource for probing viral proteins.mBio2014
24965464High-throughput identification of loss-of-function mutations for anti-interferon activity in the influenza A virus NS segment.J Virol2014
24842159HIV-1 quasispecies delineation by tag linkage deep sequencing.PLoS One2014
24820965High-throughput profiling of influenza A virus hemagglutinin gene at single-nucleotide resolution.Sci Rep2014
24722365A quantitative high-resolution genetic profile rapidly identifies sequence determinants of hepatitis C viral fitness and drug sensitivity.PLoS Pathog2014
23791193Recombinant probes for visualizing endogenous synaptic proteins in living neurons.Neuron2013
23125174Single-round, multiplexed antibody mimetic design through mRNA display.Angew Chem Int Ed Engl2012
21761516Rapid mRNA-display selection of an IL-6 inhibitor using continuous-flow magnetic separation.Angew Chem Int Ed Engl2011
21028792Importance of controlling nanotube density for highly sensitive and reliable biosensors functional in physiological conditions.ACS Nano2010
19422193Label-free, electrical detection of the SARS virus N-protein with nanowire biosensors utilizing antibody mimics as capture probes.ACS Nano2009
19364769mRNA display design of fibronectin-based intrabodies that detect and inhibit severe acute respiratory syndrome coronavirus nucleocapsid protein.J Biol Chem2009
18590330mRNA display selection of a high-affinity, modification-specific phospho-IkappaBalpha-binding fibronectin.ACS Chem Biol2008
17322532Design, expression, and stability of a diverse protein library based on the human fibronectin type III domain.Protein Sci2007
11931761Structure of the bacterial RNA polymerase promoter specificity sigma subunit.Mol Cell2002
12488007Non-classical helix-stabilizing interactions: C-H...O H-bonding between Phe and Glu side chains in alpha-helical peptides.Biophys Chem2002
12440888D/H amide isotope effect in model alpha-helical peptides.J Am Chem Soc2002
12091708Polyproline II structure in a sequence of seven alanine residues.Proc Natl Acad Sci U S A2002
11955433Crystal structure of the Bacillus stearothermophilus anti-sigma factor SpoIIAB with the sporulation sigma factor sigmaF.Cell2002
11916412Cation-pi interaction in model alpha-helical peptides.J Am Chem Soc2002
11427086Polar interactions with aromatic side chains in alpha-helical peptides: Ch...O H-bonding and cation-pi interactions.J Am Chem Soc2001
12115147Stabilization of alpha-helix structure by polar side-chain interactions: complex salt bridges, cation-pi interactions, and C-H em leader O H-bonds.Biopolymers2001
11391775Cooperative helix stabilization by complex Arg-Glu salt bridges.Proteins2001
7511927Disruption of the determinant hierarchy on a self-MHC peptide: concomitant tolerance induction to the dominant determinant and priming to the cryptic self-determinant.Int Immunol1994
7517977Limited T cell response to donor MHC peptides during allograft rejection. Implications for selective immune therapy in transplantation.J Immunol1994
1730925Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection.J Exp Med1992
1829720Dissection of binding vs. recognition functions of H-2 class-I synthetic peptides which are recognized by alloreactive cytotoxic T lymphocytes.Int J Cancer Suppl1991
1834760The thymus leukemia antigen binds human and mouse CD8.J Exp Med1991
1700053Immunogenicity and tolerogenicity of self-major histocompatibility complex peptides.J Exp Med1990
2783781Creation of H-2 class I epitopes using synthetic peptides: recognition by alloreactive cytotoxic T lymphocytes.Proc Natl Acad Sci U S A1989
  • 1 - 50 of 51

Recommended Authors

University of California san francisco
Career Start Year 2015
Number of shared co-authors 0
University of California davis
Career Start Year 2009
Number of shared co-authors 0
Biogen Inc.
Career Start Year 2006
Number of shared co-authors 1
Elucidata Corporation
Career Start Year 2005
Number of shared co-authors 1
Stanford Cardiovascular Institute (L.W., Stanford University School of Medicine
Career Start Year 2003
Number of shared co-authors 0
J. Craig Venter Institute, 9605 Medical Center Dr
Career Start Year 2001
Number of shared co-authors 0
Dana-Farber Cancer Institute, Harvard Medical School
Career Start Year 2000
Number of shared co-authors 0
University of California San Diego
Career Start Year 2000
Number of shared co-authors 2
Poornaprajna Institute of Scientific Research (PPISR)
Career Start Year 1998
Number of shared co-authors 1
Osaka university
Career Start Year 1998
Number of shared co-authors 1
Sharif University of Technology
Career Start Year 1998
Number of shared co-authors 0
University of California San Francisco
Career Start Year 1997
Number of shared co-authors 3
F. Hoffmann-La Roche Ltd.
Career Start Year 1997
Number of shared co-authors 0
Pfizer Inc.
Career Start Year 1997
Number of shared co-authors 0
Genetics and Pharmacogenomics, Merck & Co., Inc.
Career Start Year 1994
Number of shared co-authors 0
Pfizer Inc.
Career Start Year 1994
Number of shared co-authors 0
The Walter and Eliza Hall Institute of Medical Research
Career Start Year 1993
Number of shared co-authors 0
Monash Biomedicine Discovery Institute, Monash University
Career Start Year 1989
Number of shared co-authors 0
National Institute of Chemistry
Career Start Year 1988
Number of shared co-authors 0
Weizmann Institute of Science
Career Start Year 1988
Number of shared co-authors 0
Albert Einstein College of Medicine
Career Start Year 1988
Number of shared co-authors 1
Conway Institute of Biomolecular and Biomedical Research, University College Dublin
Career Start Year 1987
Number of shared co-authors 2
Albert Einstein College of Medicine
Career Start Year 1982
Number of shared co-authors 0
Sackler School of Medicine, Tel Aviv University
Career Start Year 1980
Number of shared co-authors 0
Institute of Structural and Molecular Biology, University of London
Career Start Year 1976
Number of shared co-authors 0
University of Rome 'Tor Vergata'
Career Start Year 1976
Number of shared co-authors 0
The Scripps Research Institute, USA The Skaggs Institute for Chemical Biology
Career Start Year 1975
Number of shared co-authors 3
Department of Pharmaceutical Chemistry, University of California San Francisco
Career Start Year 1974
Number of shared co-authors 0
Albert Einstein College of Medicine
Career Start Year 1968
Number of shared co-authors 1
university of california los angeles
Career Start Year 1963
Number of shared co-authors 0

Collaborators

University of California los angeles
Co-authored papers 20
Xinjiang Medical University Affiliated First Hospital
Co-authored papers 10
University of California los angeles
Co-authored papers 6
David Geffen School of Medicine, University of California los angeles
Co-authored papers 3
David Geffen School of Medicine, University of California los angeles
Co-authored papers 3
University of California los angeles
Co-authored papers 3
University of California los angeles
Co-authored papers 2
Xiangya Hospital of Central South University
Co-authored papers 2
The Rockefeller University
Co-authored papers 2
Women's Hospital, Zhejiang University
Co-authored papers 1
Cancer Research Institute, Central South University
Co-authored papers 1
Indiana University
Co-authored papers 1
University of California San Francisco
Co-authored papers 1
Co-authored papers 1
Massachusetts Institute of Technology 21 Ames St. Cambridge
Co-authored papers 1
Northwestern University Feinberg School of Medicine
Co-authored papers 1
Co-authored papers 1
David Geffen School of Medicine, University of California los angeles
Co-authored papers 1
The Second Affiliated Hospital of Zhejiang University
Co-authored papers 1
Co-authored papers 1
David Geffen School of Medicine at university of california los angeles
Co-authored papers 1
University of California los angeles
Co-authored papers 1
university of california los angeles
Co-authored papers 1
University of California los angeles
Co-authored papers 1
Co-authored papers 1
Institute for Biophysical Dynamics, The University of Chicago
Co-authored papers 1
University of North Carolina
Co-authored papers 1
Amgen Inc.
Co-authored papers 1
J. David Gladstone Institutes
Co-authored papers 1
Co-authored papers 1